Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionTrimTabs Asset Management, LLC
Latest Disclosed Ownership82,574 shares
Latest Disclosed Value $ 11,508,338
TrimTabs Asset Management, LLC reports 41.84% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 8, 2026 - TrimTabs Asset Management, LLC filed a 13F-HR form disclosing ownership of 82,574 shares of Gilead Sciences, Inc. (CH:GILD) valued at $11,508,338 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 141,974 shares of Gilead Sciences, Inc.. This represents a change in shares of -41.84% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-08 2026-03-31 13F Gilead Sciences COM 375558103 82,574 -59,400 -41.84 11,508 -33.96 2.5901
2026-01-29 2025-12-31 13F Gilead Sciences COM 375558103 141,974 3,300 2.38 17,426 13.21 2.2762
2025-10-20 2025-09-30 13F Gilead Sciences COM 375558103 138,674 -26,340 -15.96 15,393 -15.87 2.0460
2025-07-11 2025-06-30 13F Gilead Sciences COM 375558103 165,014 2,828 1.74 18,295 0.68 2.5641
2025-04-15 2025-03-31 13F Gilead Sciences COM 375558103 162,186 36,309 28.84 18,173 56.29 2.8541
2025-02-13 2024-12-31 13F Gilead Sciences COM 375558103 125,877 50,408 66.79 11,627 83.77 1.5304
2024-10-08 2024-09-30 13F Gilead Sciences COM 375558103 75,469 5,837 8.38 6,327 32.45 1.4672
2024-07-18 2024-06-30 13F Gilead Sciences COM 375558103 69,632 6,749 10.73 4,777 3.71 1.1871
2024-04-12 2024-03-31 13F Gilead Sciences COM 375558103 62,883 5,077 8.78 4,606 -1.62 1.1521
2024-01-04 2023-12-31 13F Gilead Sciences COM 375558103 57,806 34,349 146.43 4,683 166.48 1.3598
2023-10-10 2023-09-30 13F Gilead Sciences COM 375558103 23,457 -635 -2.64 1,758 -5.33 0.9342
2023-07-19 2023-06-30 13F Gilead Sciences COM 375558103 24,092 -158 -0.65 1,857 -7.75 0.9362
2023-04-19 2023-03-31 13F GILEAD SCIENCES COM 375558103 24,250 10,633 78.09 2,012 72.11 1.0782
2023-02-03 2022-12-31 13F GILEAD SCIENCES COM 375558103 13,617 -306 -2.20 1,169 36.25 0.7627
2022-10-12 2022-09-30 13F GILEAD SCIENCES COM 375558103 13,923 -1,020 -6.83 858 -7.14 0.5912
2022-07-20 2022-06-30 13F GILEAD SCIENCES COM 375558103 14,943 -8,937 -37.42 924 -34.93 0.5662
2022-04-28 2022-03-31 13F Gilead Sciences COM 375558103 23,880 23,880 1,420 0.4752
2021-01-12 2020-12-31 13F GILEAD SCIENCES COM 375558103 0 -27,033 -100.00 0 -100.00
2020-10-20 2020-09-30 13F GILEAD SCIENCES COM 375558103 27,033 9,702 55.98 1,725 30.39 0.9270
2020-07-10 2020-06-30 13F GILEAD SCIENCES COM 375558103 17,331 -770 -4.25 1,323 0.38 1.2564
2020-04-21 2020-03-31 13F GILEAD SCIENCES COM 375558103 18,101 18,101 1,318 1.5070
2017-08-07 2017-06-30 13F GILEAD SCIENCES CL B 375558103 0 -1,323 -100.00 0 -100.00
2017-05-08 2017-03-31 13F GILEAD SCIENCES CL B 375558103 1,323 624 89.27 90 80.00 0.7433
2017-01-17 2016-12-31 13F GILEAD SCIENCES CL B 375558103 699 395 129.93 50 108.33 0.8328
2016-11-04 2016-09-30 13F GILEAD SCIENCES COM 375558103 304 304 0.00 24 0.9627
2016-08-01 2016-06-30 13F GILEAD SCIENCES COM 375558103 0 -15,441 -100.00 0 -100.00
2016-05-04 2016-03-31 13F GILEAD SCIENCES COM 375558103 15,441 -4,430 -22.29 1,418 -29.49 0.8109
2016-02-11 2015-12-31 13F GILEAD SCIENCES COM 375558103 19,871 369 1.89 2,011 5.01 0.9210
2015-12-24 2015-09-30 13F GILEAD SCIENCES COM 375558103 19,502 -1,476 -7.04 1,915 -22.03 0.9878
2015-12-24 2015-06-30 13F GILEAD SCIENCES COM 375558103 20,978 -420 -1.96 2,456 16.95 1.0684
2015-12-24 2015-03-31 13F GILEAD SCIENCES COM 375558103 21,398 21,398 2,100 1.0294
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.